United States· US:42571-160_3a71d6d7-6111-a0f8-e063-6394a90aa0e7
AMOXICILLIN AND CLAVULANATE POTASSIUM
A penicillins with extended spectrum product containing amoxicillin and clavulanate potassium, registered in United States by Micro Labs Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Amoxicillin and Clavulanate Potassium
- Manufacturer
- Micro Labs Limited
- Country
- United States (US)
- ATC code
- J01CA
- ATC class
- Penicillins with extended spectrum
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 3
- ndc114257116001100 TABLET, FILM COATED in 1 BOTTLE (42571-160-01)
- ndc11425711601110 BLISTER PACK in 1 CARTON (42571-160-11) / 10 TABLET, FILM COATED in 1 BLISTER PACK (42571-160-32)
- ndc11425711603030 TABLET, FILM COATED in 1 BOTTLE (42571-160-30)
Regulatory notes
Same class
Other records under J01CA
Penicillins with extended spectrum, as other registers publish it.
- United StatesAmoxicillin and Clavulanate PotassiumNuCare Pharmaceuticals,Inc.
- United StatesAmoxicillin and Clavulanate PotassiumNorthwind Health Company, LLC
- United StatesAmoxicillin and Clavulanate PotassiumNuCare Pharmaceuticals,Inc.
- United StatesAMOXICILLIN AND CLAVULANATE POTASSIUMNorthwind Health Company, LLC
- United StatesAMOXICILLIN AND CLAVULANATE POTASSIUMMicro Labs Limited
- United StatesAMOXICILLIN AND CLAVULANATE POTASSIUMProficient Rx LP
- United StatesAMOXICILLIN AND CLAVULANATE POTASSIUMREMEDYREPACK INC.
- United StatesAMOXICILLIN AND CLAVULANATE POTASSIUMMicro Labs Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f463c3b7-6b71-450e-8e38-5dad169b6032 GET /v1/drugs/f463c3b7-6b71-450e-8e38-5dad169b6032?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "804826J2HU",
"rxcui": "133008",
"inchikey": "MQXQVCLAUDMCEF-CWLIKTDRSA-N",
"display_name": "AMOXICILLIN",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"263a2902-f85c-46b6-8d5b-8c99f5c4b706": {
"match": "brand_token",
"title": "AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]",
"spl_version": "1",
"published_date": "2026-06-01"
}
},
"productid": "42571-160_3a71d6d7-6111-a0f8-e063-6394a90aa0e7",
"productndc": "42571-160",
"dosage_form": "TABLET, FILM COATED",
"orange_book": {
"appl_no": "205707",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "250MG;EQ 125MG BASE",
"product_no": "001",
"approval_date": "Dec 30, 2016"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "500MG;EQ 125MG BASE",
"product_no": "002",
"approval_date": "Dec 30, 2016"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "AMOXICILLIN; CLAVULANATE POTASSIUM",
"proprietary_name": "AMOXICILLIN AND CLAVULANATE POTASSIUM",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "ANDA205707",
"marketing_category": "ANDA",
"nonproprietary_name": "Amoxicillin and Clavulanate Potassium",
"start_marketing_date": "20170301",
"active_numerator_strength": "250; 125"
}See everything about amoxicillin and clavulanate potassium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.